Late gadolinium enhancement during cardiac magnetic resonance in March 2021. Late gadolinium enhancement imaging two-chamber view (acquired 10 min after intravenous injection of 0.2 mmol/kg gadolinium-based contrast agent using a phase-sensitive inversion-recovery gradient-echo sequence) showed faint mid-wall type of hyperenhancement in the basal inferior wall segment. Cardiac magnetic resonance T2 mapping (T2-prepared steady-state free precession) basal short-axis view (A) showed significantly increased T2 values in the basal segments (up to 65 ms in the basal inferolateral segments and 59 ms in the basal anteroseptum) compared with the mid-segments (which were normal, having all T2 values <45 ms). Corresponding native T1 mapping (MOdified Look-Locker Inversion Recovery) basal short-axis view (B) showed T1 values significantly increased in the basal segments (up to 1470 ms in the basal inferior) compared with the mid-segments (which were normal, having all native T1 values <1300 ms). All cardiac magnetic resonance scans performed for this case used a 3 T scanner (MAGNETOM Skyra, Siemens Healthcare) and images were analysed with reference to expert consensus reported in the Journal of Cardiovascular Magnetic Resonance.11